Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Muscle Spasticity Global Market Report 2025
Download Free Sample Buy Now
Global Muscle Spasticity Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Muscle Spasticity Global Market Report 2025

By Drug Type (Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs), By Route Of Administration (Oral, Intramuscular, Other Routes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Muscle Spasticity Market Overview

• Muscle Spasticity market size has reached to $4.19 billion in 2024

• Expected to grow to $6.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market

• Market Trend: Development of Baclofen Oral Suspension for Muscle Spasticity

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Muscle Spasticity Market?

Muscle spasticity is a condition characterized by an abnormal increase in muscle tone or stiffness, which can interfere with movement and speech. It is often a result of damage to the brain or spinal cord that controls voluntary muscle movement.

The main types of drugs in the muscle spasticity market are baclofen, botulinum toxin, diazepam, dantrolene sodium, and others. The various routes of administration include oral, intramuscular, and others, and several distribution channels including hospital pharmacies, retail pharmacies, and online pharmacies.

Muscle Spasticity Market Size and growth rate 2025 to 2029: Graph

What Is The Muscle Spasticity Market Size 2025 And Growth Rate?

The muscle spasticity market size has grown strongly in recent years. It will grow from $4.19 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing investments in research and development, expansion of clinical indications, favorable regulatory approvals and reimbursement policies, increasing emphasis on adopting a multimodal approach, and increasing prevalence of multiple sclerosis.

What Is The Muscle Spasticity Market Growth Forecast?

The muscle spasticity market size is expected to see strong growth in the next few years. It will grow to $6.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing focus on developing patient-centric care, expansion of distribution channels, focus on improving quality of life, focus on developing targeted drug delivery systems, and discovery of biomarkers. Major trends in the forecast period include adoption of value-based reimbursement models, integration of artificial intelligence and machine learning technologies, adoption of telehealth and remote monitoring technologies, neurostimulation techniques, and regenerative medicine approaches.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. patient care by inflating prices of botulinum toxin injections and intrathecal baclofen pumps developed in France and Sweden, resulting in reduced mobility management and higher rehabilitation therapy expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Muscle Spasticity Market Segmented?

1) By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs

2) By Route Of Administration: Oral, Intramuscular, Other Routes

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Baclofen: Oral Baclofen, Intrathecal Baclofen (Pump)

2) By Botulinum Toxin: Botox (Botulinum Toxin Type A), Dysport (Botulinum Toxin Type A), Xeomin (Botulinum Toxin Type A), Myobloc (Botulinum Toxin Type B)

3) By Diazepam: Oral Diazepam, Injectable Diazepam

4) By Dantrolene Sodium: Oral Dantrolene, Injectable Dantrolene

5) By Other Drugs: Tizanidine, Clonidine, Gabapentin, Other Muscle Relaxants, Selective Serotonin Reuptake Inhibitors (SSRIs)

What Is Driving The Muscle Spasticity Market? Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market

The increasing prevalence of musculoskeletal disorders is expected to drive the muscle spasticity market going forward. Musculoskeletal disorders refer to conditions affecting the muscles, bones, and joints of the body, often causing pain, stiffness, and impaired movement. The rise in musculoskeletal cases is attributed to factors such as aging populations, sedentary lifestyles, and the increasing prevalence of chronic conditions. Muscle spasticity aims to alleviate symptoms of musculoskeletal disorders by reducing pain, improving mobility, preventing complications, and enhancing patients' overall quality of life and functional abilities. For instance, in November 2023, according to a study conducted by The Lancet, a UK-based medical journal, an estimated 494 million people globally experienced other musculoskeletal disorders in 2020, with projections indicating a potential 115% increase by 2050. Moreover, in May 2022, according to Amgen, a US-based biopharmaceutical company, the annual number of fractures due to osteoporosis is expected to increase by 68% from 1.9 million in 2018 to 3.2 million by 2040. Therefore, the increasing prevalence of musculoskeletal disorders is driving the muscle spasticity industry.

Who Are The Major Players In The Global Muscle Spasticity Market?

Major companies operating in the muscle spasticity market are F. Hoffmann-La Roche AG, AbbVie Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc., Merz Pharmaceuticals GmbH, Beximco Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Revance Therapeutics Inc., Acorda Therapeutics Inc., Mylan N.V., Camber Pharmaceuticals Inc., Saol Therapeutics Inc., Zydus Cadila

What Are The Key Trends Of The Global Muscle Spasticity Market? Development of Baclofen Oral Suspension for Muscle Spasticity

Major companies operating in the muscle spasticity market are focusing on developing oral suspensions to treat muscle spasms associated with conditions such as multiple sclerosis and spinal cord injuries. Oral suspensions are liquid medications with dispersed active ingredients taken by mouth. For instance, in April 2024, ANI Pharmaceuticals, a US-based pharmaceutical manufacturing company, launched baclofen oral suspension. Baclofen oral suspension, a generic version of fleqsuvy is used to treat muscle spasms caused by conditions such as multiple sclerosis and spinal cord injuries by helping to relax the muscles.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Muscle Spasticity Market? Amneal Pharmaceuticals Acquisition of Saol Therapeutics Baclofen Product Line

In January 2022, Amneal Pharmaceuticals Inc., a US-based pharmaceutical manufacturing company, acquired Saol Therapeutics baclofen franchise, including lioresal and lyvispahtm, for approximately $83.5 million. The acquisition aims to bolster Amneal Pharmaceuticals' neurology portfolio and institutional market presence while facilitating its entry into the biosimilar market with anticipated revenue growth from the acquired Baclofen franchise by 2025. Saol Therapeutics is a US-based pharmaceutical company specializing in developing and commercializing treatments for limb spasticity and pain related to knee osteoarthritis.

What Is The Regional Outlook For The Global Muscle Spasticity Market?

North America was the largest region in the muscle spasticity market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Muscle Spasticity Market?

The muscle spasticity market consists of revenues earned by entities by providing services such as pharmaceutical treatments, physical therapy, and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle spasticity market also includes sales of tizanidine, gabapentin, and pregabalin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Muscle Spasticity Industry?

The muscle spasticity market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the muscle spasticity industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Muscle Spasticity Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.55 billion
Revenue Forecast In 2034 $6.37 billion
Growth Rate CAGR of 8.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs
2) By Route Of Administration: Oral, Intramuscular, Other Routes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Baclofen: Oral Baclofen, Intrathecal Baclofen (Pump)
2) By Botulinum Toxin: Botox (Botulinum Toxin Type A), Dysport (Botulinum Toxin Type A), Xeomin (Botulinum Toxin Type A), Myobloc (Botulinum Toxin Type B)
3) By Diazepam: Oral Diazepam, Injectable Diazepam
4) By Dantrolene Sodium: Oral Dantrolene, Injectable Dantrolene
5) By Other Drugs: Tizanidine, Clonidine, Gabapentin, Other Muscle Relaxants, Selective Serotonin Reuptake Inhibitors (SSRIs)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, AbbVie Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc., Merz Pharmaceuticals GmbH, Beximco Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Revance Therapeutics Inc., Acorda Therapeutics Inc., Mylan N.V., Camber Pharmaceuticals Inc., Saol Therapeutics Inc., Zydus Cadila
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Muscle Spasticity Market Characteristics

3. Muscle Spasticity Market Trends And Strategies

4. Muscle Spasticity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Muscle Spasticity Growth Analysis And Strategic Analysis Framework

5.1. Global Muscle Spasticity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Muscle Spasticity Market Growth Rate Analysis

5.4. Global Muscle Spasticity Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Muscle Spasticity Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Muscle Spasticity Total Addressable Market (TAM)

6. Muscle Spasticity Market Segmentation

6.1. Global Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Baclofen

Botulinum Toxin

Diazepam

Dantrolene Sodium

Other Drugs

6.2. Global Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intramuscular

Other Routes

6.3. Global Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Muscle Spasticity Market, Sub-Segmentation Of Baclofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Baclofen

Intrathecal Baclofen (Pump)

6.5. Global Muscle Spasticity Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Botox (Botulinum Toxin Type A)

Dysport (Botulinum Toxin Type A)

Xeomin (Botulinum Toxin Type A)

Myobloc (Botulinum Toxin Type B)

6.6. Global Muscle Spasticity Market, Sub-Segmentation Of Diazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Diazepam

Injectable Diazepam

6.7. Global Muscle Spasticity Market, Sub-Segmentation Of Dantrolene Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Dantrolene

Injectable Dantrolene

6.8. Global Muscle Spasticity Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tizanidine

Clonidine

Gabapentin

Other Muscle Relaxants

Selective Serotonin Reuptake Inhibitors (SSRIs)

7. Muscle Spasticity Market Regional And Country Analysis

7.1. Global Muscle Spasticity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Muscle Spasticity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Muscle Spasticity Market

8.1. Asia-Pacific Muscle Spasticity Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Muscle Spasticity Market

9.1. China Muscle Spasticity Market Overview

9.2. China Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Muscle Spasticity Market

10.1. India Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Muscle Spasticity Market

11.1. Japan Muscle Spasticity Market Overview

11.2. Japan Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Muscle Spasticity Market

12.1. Australia Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Muscle Spasticity Market

13.1. Indonesia Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Muscle Spasticity Market

14.1. South Korea Muscle Spasticity Market Overview

14.2. South Korea Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Muscle Spasticity Market

15.1. Western Europe Muscle Spasticity Market Overview

15.2. Western Europe Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Muscle Spasticity Market

16.1. UK Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Muscle Spasticity Market

17.1. Germany Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Muscle Spasticity Market

18.1. France Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Muscle Spasticity Market

19.1. Italy Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Muscle Spasticity Market

20.1. Spain Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Muscle Spasticity Market

21.1. Eastern Europe Muscle Spasticity Market Overview

21.2. Eastern Europe Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Muscle Spasticity Market

22.1. Russia Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Muscle Spasticity Market

23.1. North America Muscle Spasticity Market Overview

23.2. North America Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Muscle Spasticity Market

24.1. USA Muscle Spasticity Market Overview

24.2. USA Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Muscle Spasticity Market

25.1. Canada Muscle Spasticity Market Overview

25.2. Canada Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Muscle Spasticity Market

26.1. South America Muscle Spasticity Market Overview

26.2. South America Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Muscle Spasticity Market

27.1. Brazil Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Muscle Spasticity Market

28.1. Middle East Muscle Spasticity Market Overview

28.2. Middle East Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Muscle Spasticity Market

29.1. Africa Muscle Spasticity Market Overview

29.2. Africa Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Muscle Spasticity Market Competitive Landscape And Company Profiles

30.1. Muscle Spasticity Market Competitive Landscape

30.2. Muscle Spasticity Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Muscle Spasticity Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.

31.2. Boston Scientific Corporation

31.3. Sun Pharmaceutical Industries Ltd.

31.4. Ipsen Pharma

31.5. Hikma Pharmaceuticals plc

31.6. Endo Pharmaceuticals Inc.

31.7. Lupin Pharmaceuticals Inc.

31.8. Amneal Pharmaceuticals Inc.

31.9. Mallinckrodt Pharmaceuticals

31.10. Neurocrine Biosciences Inc.

31.11. Merz Pharmaceuticals GmbH

31.12. Beximco Pharmaceuticals Ltd.

31.13. ANI Pharmaceuticals Inc.

31.14. Taj Pharmaceuticals Limited

31.15. Revance Therapeutics Inc.

32. Global Muscle Spasticity Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscle Spasticity Market

34. Recent Developments In The Muscle Spasticity Market

35. Muscle Spasticity Market High Potential Countries, Segments and Strategies

35.1 Muscle Spasticity Market In 2029 - Countries Offering Most New Opportunities

35.2 Muscle Spasticity Market In 2029 - Segments Offering Most New Opportunities

35.3 Muscle Spasticity Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Muscle Spasticity Market, Sub-Segmentation Of Baclofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Muscle Spasticity Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Muscle Spasticity Market, Sub-Segmentation Of Diazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Muscle Spasticity Market, Sub-Segmentation Of Dantrolene Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Muscle Spasticity Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Muscle Spasticity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Muscle Spasticity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: F. Hoffmann-La Roche AG Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Abbott Laboratories Financial Performance
  • Table 82: Novartis AG Financial Performance
  • Table 83: Medtronic plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Muscle Spasticity Market, Sub-Segmentation Of Baclofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Muscle Spasticity Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Muscle Spasticity Market, Sub-Segmentation Of Diazepam, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Muscle Spasticity Market, Sub-Segmentation Of Dantrolene Sodium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Muscle Spasticity Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Muscle Spasticity Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Muscle Spasticity Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Muscle Spasticity Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Muscle Spasticity Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Muscle Spasticity Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: F. Hoffmann-La Roche AG Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Abbott Laboratories Financial Performance
  • Figure 82: Novartis AG Financial Performance
  • Figure 83: Medtronic plc Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

Read More About Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Muscle Spasticity Global Market Report 2025 – By Drug Type (Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Other Drugs), By Route Of Administration (Oral, Intramuscular, Other Routes), By Distribution Channel (H...

View Report

Muscle Wasting Disorders Global Market Report 2025 – By Treatment Type (Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types), By Disorder Type (Muscular Dystrophy, Amyotrophic...

View Report

Muscle Tension Dysphonia Treatment Global Market Report 2025 – By Treatment Type (Drugs, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Proton-Pump Inhibitors, Analgesics, Antacids, Voice Therapy, Behavioral Counseling),...

View Report

Muscle Pain Treatment Global Market Report 2025 – By Pharmacological Treatment (Analgesics, Muscle Relaxants, Topical Analgesics, Other Pharmacological Treatments), By Non-Pharmacological Treatment (Physical Therapy, Mas...

View Report

Muscle Relaxant Drugs Global Market Report 2025 – By Drug Type( Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Formulation( Cyclobenzaprine, Carisoprodol, Chlorzoxazone, ...

View Report

Sciatica Global Market Report 2025 – By Type (Acute Sciatica, Chronic Sciatica, Other Types), By Drugs (Oxycodone, Tramadol, Opioid Analgesics, Amitriptyline, Tricyclic Antidepressants, Other Drugs), By Treatment (Medica...

View Report

Muscle Relaxant Drugs Global Market Report 2025 – By Drug Type( Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Formulation( Cyclobenzaprine, Carisoprodol, Chlorzoxazone, ...

View Report

Duchenne Muscular Dystrophy Global Market Report 2025 – By Therapy (Mutation Suppression, Exon Skipping Approach), By Therapeutic Class (Molecular Based Therapies, Steroid Therapy), By Route of Administration (Oral, Pare...

View Report

Frequently Asked Questions

Muscle spasticity is a condition characterized by an abnormal increase in muscle tone or stiffness, which can interfere with movement and speech. It is often a result of damage to the brain or spinal cord that controls voluntary muscle movement. For further insights on this market, request a sample here

The market major growth driver - Impact Of Rising Musculoskeletal Disorders On The Muscle Pain Treatment Market. For further insights on this market, request a sample here

The muscle spasticity market size has grown strongly in recent years. It will grow from $4.19 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing investments in research and development, expansion of clinical indications, favorable regulatory approvals and reimbursement policies, increasing emphasis on adopting a multimodal approach, and increasing prevalence of multiple sclerosis. The muscle spasticity market size is expected to see strong growth in the next few years. It will grow to " $6.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing focus on developing patient-centric care, expansion of distribution channels, focus on improving quality of life, focus on developing targeted drug delivery systems, and discovery of biomarkers. Major trends in the forecast period include adoption of value-based reimbursement models, integration of artificial intelligence and machine learning technologies, adoption of telehealth and remote monitoring technologies, neurostimulation techniques, and regenerative medicine approaches. For further insights on this market, request a sample here

The muscle spasticitymarket covered in this report is segmented –
1) By Drug Type: Baclofen; Botulinum Toxin; Diazepam; Dantrolene Sodium; Other Drugs
2) By Route Of Administration: Oral; Intramuscular; Other Routes
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies Subsegments:
1) By Baclofen: Oral Baclofen; Intrathecal Baclofen (Pump)
2) By Botulinum Toxin: Botox (Botulinum Toxin Type A); Dysport (Botulinum Toxin Type A); Xeomin (Botulinum Toxin Type A); Myobloc (Botulinum Toxin Type B)
3) By Diazepam: Oral Diazepam; Injectable Diazepam
4) By Dantrolene Sodium: Oral Dantrolene; Injectable Dantrolene
5) By Other Drugs: Tizanidine; Clonidine; Gabapentin; Other Muscle Relaxants; Selective Serotonin Reuptake Inhibitors (SSRIs) For further insights on this market, request a sample here

North America was the largest region in the muscle spasticity market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle spasticity market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the muscle spasticity market are F. Hoffmann-La Roche AG, AbbVie Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Neurocrine Biosciences Inc., Merz Pharmaceuticals GmbH, Beximco Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Taj Pharmaceuticals Limited, Revance Therapeutics Inc., Acorda Therapeutics Inc., Mylan N.V., Camber Pharmaceuticals Inc., Saol Therapeutics Inc., Zydus Cadila . For further insights on this market, request a sample here.

Major trends in this market include Development of Baclofen Oral Suspension for Muscle Spasticity. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Muscle Spasticity Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon